You are using a version of the website built for webcrawlers and people whose devices cannot use javascript. Some functionality may not be available.
Contents (2008 - 392)
Skip contents
Poisons and Therapeutic Goods Regulation 2008
Current version for 1 July 2017 to date (accessed 25 September 2017 at 01:35)
Part 4 Division 3 Clause 84
84   Exceptions to section 28—prescriptions for amphetamines and nabiximols
(1)  This clause applies to the following substances:
amphetamine
dexamphetamine
lisdexamfetamine
methylamphetamine
methylphenidate
nabiximols
phendimetrazine
phenmetrazine
(2)  A medical practitioner is authorised to issue a prescription for dexamphetamine, lisdexamfetamine or methylphenidate for a person without an authority under section 29 of the Act:
(a)  for the purpose of testing the suitability of the person to undergo a course of medical treatment involving the use of such a substance, or
(b)  for the purpose of treating the person for attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD),
so long as the medical practitioner holds an authority under Part 8 to prescribe such a substance.
(3)  An authorised practitioner (other than a medical practitioner) must not issue a prescription for a substance to which this clause applies.
Maximum penalty: 20 penalty units.